Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Update

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 132,400 shares, a growth of 16.5% from the January 15th total of 113,600 shares. Currently, 0.6% of the company's shares are short sold. Based on an average daily trading volume, of 184,500 shares, the short-interest ratio is presently 0.7 days.

Rapid Micro Biosystems Stock Down 4.6 %

Shares of Rapid Micro Biosystems stock traded down $0.18 during trading on Wednesday, hitting $3.72. 743,498 shares of the company were exchanged, compared to its average volume of 421,415. The stock has a market capitalization of $160.07 million, a price-to-earnings ratio of -3.32 and a beta of 1.26. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $4.04. The firm has a 50 day moving average price of $1.66 and a 200 day moving average price of $1.19.

Analysts Set New Price Targets

Separately, KeyCorp initiated coverage on Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an "overweight" rating and a $8.00 target price on the stock.

Institutional Trading of Rapid Micro Biosystems

A number of hedge funds and other institutional investors have recently modified their holdings of RPID. Millennium Management LLC increased its holdings in shares of Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after acquiring an additional 9,191 shares during the last quarter. Citadel Advisors LLC acquired a new stake in Rapid Micro Biosystems during the fourth quarter worth about $65,000. Finally, Renaissance Technologies LLC boosted its stake in Rapid Micro Biosystems by 122.9% in the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after acquiring an additional 100,942 shares during the period. 52.60% of the stock is owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.